Vol 2005, No 60 (2005)

Table of Contents

Deal Trackers

Symlin (pramlintide) Abstract pdf
Business Review Editor

Research & Development

BioGeneriX to Develop Second Protein Using Neose’s GlycoPEGylation(TM) Technology Abstract pdf
Business Review Editor
AVANIR Pharmaceuticals Lands Research Deal with Novartis Abstract pdf
Business Review Editor

Features

Novartis Chooses the UK for High-Value COPD Alliance Abstract pdf
Business Review Editor
Dividing Opinion: Shire's Move to Purchase TKT Abstract pdf
Business Review Editor
Generics Companies: Moving Up the Food Chain Abstract pdf
Business Review Editor
Therapy Focus: Cancer Vaccines Abstract pdf
Business Review Editor

Licensing

Genmab Licenses Preclinical-Stage Antibody to Serono Abstract pdf
Business Review Editor

General

BMS Out-Licenses Two Early-Stage Drugs Abstract
Business Review Editor
Arakis Ltd Abstract pdf
Business Review Editor

Mergers & Acquisitions

Genzyme Offers US$600 M for Bone Care Abstract pdf
Business Review Editor
GlaxoSmithKline Agrees to Buy Biopharmaceutical Company Corixa Abstract pdf
Business Review Editor

Distribution & Marketing

Kos strengthens Cardiovascular Portfolio as Biovail Restructures Abstract pdf
Business Review Editor

Business Commentaries

Supply and Demand Will Shape the Future of Equity-Based Transactions html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.